Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: J Vasc Interv Radiol. 2010 Aug 5;21(9):1377–1384. doi: 10.1016/j.jvir.2010.04.027

Table 4.

Non-embolic trans-arterial therapies for HCC - median survival in patients with PVT.

Treatment PVT Type N Median (months) 95% CI* (months)
90Y-microspheres (31) IVC/main/1st 15 3.2
90Y-microspheres (13) Main 12 4.4 3–7
Hepatic arterial infusion chemotherapy (32) Main/1st 45 6
90Y-microspheres (current study) Main/1st 22 7 4–18
Continuous hepatic arterial infusion chemotherapy (25) Main/branch 52 8
90Y-microspheres (13) Branch (1st) 25 10 7–16
*

CI: confidence interval